NOD SCID
Nomenclature
NOD.Cg-Prkdcscid/NifdcSmoc
Cat. NO.
SM-019
Strain State
Repository Live
Model Description
Validation Data

Fig1. Body weight growth curve of NOD SCID (n=1046)

Fig 2. Detection of serum antibody subclasses in NOD SCID mice (8-week old, male).

Fig3. Complete deletion of T, B and NK cells of NOD SCID mice. Spleen and peripheral blood cells NOD SCID mice were collected to analyze their compositions of T, B and NK cells by FACS.

Fig4. Complete deletion of Monocytes, macrophages and DC cells of NOD SCID mice. Spleen and peripheral blood cells NOD SCID mice were collected to analyze their compositions of Monocytes, macrophages and DC cells by FACS.
Fig5. Pathological examination of various tissues in NOD SCID mice. Thymus was absent in NOD SCID mice, and no significant pathologic abnormalities were found in the other tissues examined (8-week old, A males, B females).

Fig6. Subcutaneous xenograft tumor growth in NOD SCID.

Fig7. Blood routine tests in NOD SCID.

Fig8. Blood biochemistry in NOD SCID.
Table 1. NOD SCID xenograft cell lines

You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreSMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more